Ablitech, Inc. is a biotechnology company founded in Hattiesburg, Mississippi, USA, that specializes in the development and commercialization of platform technologies that heal and protect the human body.[1]
History
editAblitech was co-founded in 2006 by Dr. Lisa Kemp, Dr. Nick Hammond and Dr. Kenneth Malone on technology licensed from The University of Southern Mississippi.
The formation of Ablitech was a direct result of the National Science Foundation program IGERT – an “interdisciplinary training program, educating U.S. Ph.D. scientists and engineers by building on the foundations of their disciplinary knowledge with interdisciplinary training.” [2][3][4]
In 2007, Ablitech received a SBIR Phase I for the development of a bio-transformable drug-eluting coronary stent.[5] Then in 2008 they received another SBIR Phase I for the development of a cancer therapy.[6]
Ablitech received the Mississippi Seed Fund Research and Development investment in 2009 and in 2010.[7] Managed by the Mississippi Technology Alliance, the Mississippi Seed Fund provides high-tech, start-up companies with access to pre-seed financing, early stage risk capital, and product development capital to stimulate and accelerate the development of high-performance, technology-based business ventures in Mississippi.[8]
In 2011, Ablitech received a $2 million grant from the Department of Defense to develop a siRNA based therapy for heterotopic ossification.[9]
Location
editAblitech is located at the University of Maryland BioPark. The corporation relocated to Baltimore, Maryland in early 2012.[10]
Research
editAblitech's signature product, VersadelTM, is a nucleic acid platform delivery technology that “provides a non-toxic, biocompatible method for the systemic and local delivery of antisense DNA and siRNA in the body.” [11]
Awards
editReferences
edit- ^ Ablitech’s Mission Statement. Retrieved 1/07/2011: http://www.ablitech.com.
- ^ National Science Foundation. 2007. Young Inventors’ Research Transforms the Marketplace. Retrieved 1/07/2010: https://www.nsf.gov/news/news_summ.jsp?cntn_id=109819&org=DGE&from=news.
- ^ Mississippi Gulf Coast Alliance for Economic Development. 2009. Could Ablitech Change Cancer Treatment? Retrieved 1/07/2011: http://www.mscoastaerospace.com/files/q109_newsletter.pdf Archived 2011-07-14 at the Wayback Machine.
- ^ IGERT – About IGERT. Retrieved 1/07/2011: http://www.igert.org/public/about.
- ^ Noetic Technologies. 2007. Ablitech, Inc. Receives $100,000 Grant from NSF. Retrieved 1/07/2011: http://www.noetictechnologies.org/news/ablitech_receives_grant.html Archived 2011-07-27 at the Wayback Machine.
- ^ Research Watch. SBIR Phase I: PolyRNA –A Radical Innovation for Healing the Human Body. Retrieved 1/07/2011: http://researchwatch.net/nsf_grants/0810755[permanent dead link].
- ^ Northway, Wally. 2010. Ablitech receives more ‘Seed’ money from MTA. The Mississippi Business Journal. Retrieved 1/07/2011: http://msbusiness.com/blog/2010/06/ablitech-receives-more-seed-money-from-mta/.
- ^ Mississippi Seed Fund. http://www.technologyalliance.ms/seed-fund/ Archived 2011-02-03 at the Wayback Machine.
- ^ Ablitech Gets $2M DoD Grant for R&D into Heterotopic Ossification. GEN. Retrieved 10/13/2011:http://www.genengnews.com/gen-news-highlights/ablitech-gets-2m-dod-grant-for-r-d-into-heterotopic-ossification/81245812/ Archived 2016-03-03 at the Wayback Machine.
- ^ Sentementes, Gus G. 2012. Mississippi biotech startup moves to Baltimore. Retrieved 12/04/2012: [1].
- ^ Wbt Innovation Marketplace. 2010. Company Profiles: Ablitech, Inc. Retrieved 10/19/2010: http://www.wbtshowcase.com/wbt/web.nsf/pages/files.html/$file/WBT2011%20Profile%20-%20Ablitech%20Inc.pdf.
- ^ Noetic Technologies – invent your future! – Hall of Fame. Retrieved 1/07/2011: http://www.noetictechnologies.com/news/IYFhalloffame.html.
- ^ The University of Memphis - FedEx Institute of Technology. 2006. NanoTect Takes Top Prize in Mid-South Business Plan Competition. Retrieved 1/07/2011: http://www.memphis.edu/fedex/releases/2006/4-04-06BusinessFInal.php Archived 2010-06-06 at the Wayback Machine.